Changes in antibiotic prescribing following COVID-19 restrictions: Lessons for post-pandemic antibiotic stewardship
- PMID: 34405427
- PMCID: PMC8444718
- DOI: 10.1111/bcp.15000
Changes in antibiotic prescribing following COVID-19 restrictions: Lessons for post-pandemic antibiotic stewardship
Abstract
Aims: Public health responses to reduce SARS-CoV-2 transmission have profoundly affected the epidemiology and management of other infections. We examined the impact of COVID-19 restrictions on antibiotic dispensing in Australia.
Methods: We used national claims data to investigate antibiotic dispensing trends from November 2015 to October 2020 and whether changes reflected reductions in primary care consultations. We used interrupted time series analysis to quantify changes in monthly antibiotic dispensing and face-to-face and telehealth GP consultations and examined changes by recipient age, pharmacy State and prescriber specialty.
Results: Over the study period, an estimated 19 921 370 people had 125 495 137 antibiotic dispensings, 71% prescribed by GPs. Following COVID-19 restrictions, we observed a sustained 36% (95% CI: 33-40%) reduction in antibiotic dispensings from April 2020. Antibiotics recommended for managing respiratory tract infections showed large reductions (range 51-69%), whereas those recommended for non-respiratory infections were unchanged. Dispensings prescribed by GPs decreased from 63.5 per 1000 population for April-October 2019 to 37.0 per 1000 for April-October 2020. Total GP consultation rates remained stable, but from April 2020, 31% of consultations were telehealth.
Conclusion: In a setting with a low COVID-19 incidence, restrictions were associated with a substantial reduction in community dispensings of antibiotics primarily used to treat respiratory infections, coincident with reported reductions in respiratory viral infections. Our findings are informative for post-pandemic antimicrobial stewardship and highlight the potential to reduce inappropriate prescribing by GPs and specialists for respiratory viral infections.
Keywords: Australia; COVID-19; antibiotics; epidemiology; physical distancing.
© 2021 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
Conflict of interest statement
H.Z., A.L.S., M.B.G. and S.A.P. are employed by the Centre for Big Data Research in Health, UNSW Sydney, which received funding in 2020 from AbbVie Australia to conduct research, unrelated to this study. The remaining authors report no actual, potential or perceived conflict of interest regarding the submission of this manuscript.
Figures




Comment in
-
Reductions in Antibiotic Prescribing in Australia During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: National Prescribing Data.Clin Infect Dis. 2022 Aug 24;75(1):e1202-e1203. doi: 10.1093/cid/ciac277. Clin Infect Dis. 2022. PMID: 35403687 Free PMC article. No abstract available.
References
-
- Sutherland K, Chessman J, Zhao J, et al. Impact of COVID‐19 on healthcare activity in NSW, Australia. Public Health Res Pract. 2020;30(4):e3042030. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous